Uncovering cellular senescence as a therapeutic target in NF2-related vestibular schwannoma
These findings suggest that a one-two punch strategy of pro-senescence therapy induced by chemotherapy treatment followed by senolytic therapy represents a new paradigm for the pharmacological treatment of VS.
Authors
- Ana M Jiménez-Lara
- Isabel Varela‐Nieto (ORCID: https://orcid.org/0000-0003-3077-0500)
- Luis Lassaletta (ORCID: https://orcid.org/0000-0002-8260-4523)
- Julio R. Contreras (ORCID: https://orcid.org/0000-0002-2145-4090)
- Sandra Franco-Caspueñas
- Carmen García-Montoya
Institutions
- Instituto Cajal (ES)
- Hospital La Paz Institute for Health Research (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Hearing Research
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.heares.2024.109165
- Citations
- 3
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.74